ArticleInternal medicine (Tokyo, Japan)2019

Clinical Features, Pathological Features, and Treatment Outcomes of 22 Patients with Aggressive Adult T-cell Leukemia-lymphoma Treated with a Humanized CCR4 Antibody (Mogamulizumab) at a Single Institution during a 6-year Period (2012-2018).

Noriaki Kawano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.